Search

Your search keyword '"Linhardt, Robert J."' showing total 64 results

Search Constraints

Start Over You searched for: Author "Linhardt, Robert J." Remove constraint Author: "Linhardt, Robert J." Database OAIster Remove constraint Database: OAIster
64 results on '"Linhardt, Robert J."'

Search Results

1. Expedient Synthesis of a Library of Heparan Sulfate Like “Head to Tail” Linked Multimers for Structure and Activity Relationship Studies

2. Strong reduction of the chain rigidity of hyaluronan by selective binding of Ca2+ ions

3. Strong reduction of the chain rigidity of hyaluronan by selective binding of Ca2+ ions

4. Strong Reduction of the Chain Rigidity of Hyaluronan by Selective Binding of Ca2+ Ions

5. Strong reduction of the chain rigidity of hyaluronan by selective binding of Ca2+ ions

6. Strong reduction of the chain rigidity of hyaluronan by selective binding of Ca2+ ions

7. Strong Reduction of the Chain Rigidity of Hyaluronan by Selective Binding of Ca2+ Ions

8. FAM20B-catalyzed glycosaminoglycans control murine tooth number by restricting FGFR2b signaling.

9. FAM20B-catalyzed glycosaminoglycans control murine tooth number by restricting FGFR2b signaling.

10. Remote Sensing of Sea Ice on the MOSAiC Ice Floe

11. Streamlined synthesis of core disaccharide building blocks from natural polysaccharides for the generation of heparan sulfate libraries

12. Heavy Heparin: A Stable Isotope-Enriched, Chemoenzymatically-Synthesized, Poly-Component Drug.

13. A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships.

14. A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships.

15. RNA Aptamers with Specificity for Heparosan and Chondroitin Glycosaminoglycans.

16. Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission

17. Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study

18. Effect of Genomic Integration Location on Heterologous Protein Expression and Metabolic Engineering in E. coli.

19. EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay.

20. Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study

21. EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay.

22. Effect of Genomic Integration Location on Heterologous Protein Expression and Metabolic Engineering in E. coli.

23. Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study

24. Cloning and Expression of Recombinant Chondroitinase ACII and Its Comparison to the Arthrobacter aurescens Enzyme.

25. Complete Biosynthesis of Anthocyanins Using E. coli Polycultures.

26. CRISPRi-mediated metabolic engineering of E. coli for O-methylated anthocyanin production.

27. Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study

28. Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer.

29. GlycCompSoft : Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data

30. Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in Escherichia coli.

31. Synthesis and biological evaluation of 5,7-dihydroxyflavanone derivatives as antimicrobial agents.

32. Heparin's solution structure determined by small-angle neutron scattering.

33. 2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection.

34. Bioengineering murine mastocytoma cells to produce anticoagulant heparin.

35. Heparan sulfate deficiency disrupts developmental angiogenesis and causes congenital diaphragmatic hernia.

36. Bioengineering murine mastocytoma cells to produce anticoagulant heparin.

37. Heparan sulfate deficiency disrupts developmental angiogenesis and causes congenital diaphragmatic hernia.

38. Bioengineering murine mastocytoma cells to produce anticoagulant heparin

39. Heparan sulfate deficiency disrupts developmental angiogenesis and causes congenital diaphragmatic hernia

40. Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes

41. Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes

42. Orthogonal Analytical Approaches to Detect Potential Contaminants in Heparin

43. Working group report: the roles of glycans in hemostasis, inflammation and vascular biology.

44. Working group report: the roles of glycans in hemostasis, inflammation and vascular biology.

45. Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells

46. Solution structures of chemoenzymatically synthesized heparin and its precursors

Catalog

Books, media, physical & digital resources